Bibliography
- Meyer UA : Pharmacogenetics and adverse drug reactions.Lancet356 , 1667–1671 (2000).
- Weinshilboum R : Inheritance and drug response.N. Engl. J. Med.348 , 529–537 (2003).
- Bakker JA , BierauJ, DrentM: Therapeutic regimens in interstitial lung disease guided by genetic screening: fact or fiction?Eur. Respir. J.30 , 821–822 (2007).
- Shurin SB , NabelEG: Pharmacogenomics – ready for prime time?N. Engl. J. Med.358 , 1061–1063 (2008).
- Jaquenoud S irot E, van der Velden JW, Rentsch K, Eap CB, Baumann P: Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance. Drug Saf.29 , 735–768 (2006).
- Ensom MH , ChangTK, PatelP: Pharmacogenetics: the therapeutic drug monitoring of the future?Clin. Pharmacokinet.40 , 783–802 (2001).
- Wijnen PA , Op den Buijsch RA, Cheung SC et al.: Genotyping with a dried blood spot method: a useful technique for application in pharmacogenetics. Clin. Chim. Acta388 , 189–191 (2008).
- von Ahsen N , RichterM, GruppC, RingeB, OellerichM, ArmstrongVW: No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients.Clin. Chem.47 , 1048–1052 (2001).
- Cheung CY , Op den Buijsch RA, Wong KM et al.: Influence of different allelic variants of the CYP3A and ABCB1 genes on the tacrolimus pharmacokinetic profile of Chinese renal transplant recipients. Pharmacogenomics7 , 563–574 (2006).
- Wijnen PA , DrentM, NelemansPJ et al.: Role of cytochrome p450 polymorphisms in the development of pulmonary drug toxicity: a case-control study in the Netherlands.Drug Saf.31 , 1125–1134 (2008).
- Fischer A , LejczakC, LambertC et al.: Simple DNA extraction method for dried blood spots and comparison of two PCR assays for diagnosis of vertical human immunodeficiency virus type 1 transmission in Rwanda.J. Clin. Microbiol.42 , 16–20 (2004).